Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820778 · ClinicalTrials.gov registry record · NA
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
A NA study of Neurofibromatosis 1 and Plexiform Neurofibroma, sponsored by Children's National Research Institute.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03820778: Active NA study of Neurofibromatosis 1 and Plexiform Neurofibroma, sponsored by Children's National Research Institute.
NCT03820778 is a NA study of Neurofibromatosis 1 and Plexiform Neurofibroma that is active but no longer recruiting, run by Children's National Research Institute. The registered enrollment target is 10 participants, below the 1,035-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03820778, a NA study of Neurofibromatosis 1 and Plexiform Neurofibroma, is active but no longer recruiting, sponsored by Children's National Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to determine if Whole Body MRI (WBMRI) can be used to identify Atypical Neurofibromas (ANF) in Neurofibromatosis Type 1 (NF1) patients with high tumor burden. Each enrolled participant will have two (2) WBMRIs without sedation during the study period. Eligible participants must be Male or Female between the ages of 8-30 with diagnosed NF1; with one or more PN greater than 3cm in diameter and willing to comply with study procedures.
Primary Outcome
Number of NF1 participants with high tumor burden who have ANF on WBMRI
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Whole Body MRI
Study Locations (1)
District of Columbia
- Children's National Health System - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
What the registry record for NCT03820778 still lists
NCT03820778 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,035-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (99% lower).
The record links to 6 conditions, with Neurofibromatosis 1 appearing as the primary indexed condition, and to 1 intervention - of which Whole Body MRI is the first listed.
NCT03820778 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03820778 about?
NCT03820778 is a clinical study titled "Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1". This study is being conducted to determine if Whole Body MRI (WBMRI) can be used to identify Atypical Neurofibromas (ANF) in Neurofibromatosis Type 1 (NF1) patients with high tumor burden. Each enrolled participant will have two (2) WBMRIs without sedation during the study period. Eligible participa...
What is the current status of trial NCT03820778?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-12. Estimated completion is 2022-08-01.
What conditions does trial NCT03820778 study?
This clinical trial studies the following conditions: Neurofibromatosis 1, Plexiform Neurofibroma, Neurofibroma, Atypical Neurofibroma, Von Recklinghausen Disease.
What interventions are being tested in trial NCT03820778?
The interventions under investigation include: Whole Body MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03820778?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03820778 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03820778's enrollment target sits among peer trials
10 25th of 24 the lowest of 24 other Neurofibromatosis 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurofibromatosis 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
RECRUITING · NA
-
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
RECRUITING · NA
-
Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
RECRUITING · NA
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RECRUITING
-
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RECRUITING · Phase 1
-
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI